Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2024-02-08 | 2024-04-18 | 218974 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2024-03-18 | 2024-04-11 | 222566 |
| ACT QUETIAPINE | 200MG | TABLET | Resolved | 2025-08-08 | 2025-10-10 | 264810 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2025-11-13 | 2025-11-20 | 271796 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-15 | 2020-12-03 | 126516 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-22 | 2020-11-26 | 126909 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2021-01-22 | 2021-05-06 | 132276 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2022-03-04 | 2022-04-21 | 156058 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2023-04-27 | 2023-08-18 | 190734 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195781 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2025-05-02 | 2025-05-22 | 256459 |
| ACT RANITIDINE | 300MG | TABLET | Resolved | 2017-03-17 | 2017-09-19 | 3320 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86927 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94846 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94849 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94852 |
| ACT RANITIDINE | 300MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94855 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2020-01-24 | 2020-05-14 | 104307 |
| ACT REPAGLINIDE | 0.5MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149591 |
| ACT REPAGLINIDE | 1MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149596 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |